Helen Torley Halozyme Therapeutics, Inc. (HALO) insider trading activity

HALO Quotes by TradingView

Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 666,744 shares of HALO, which is worth approximately $31.4 Million. The most recent transaction as insider was on Nov 25, 2020, when has been sold 50,000 shares (Common Stock) at a price of $14.66 per share, resulting in proceeds of $733,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 667K
1.48% 3M change
6.91% 12M change
Total Value Held $31.4 Million

Helen Torley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 25 2020
BUY
Exercise of conversion of derivative security
$733,000 $14.66 p/Share
50,000 Added 8.61%
530,522 Common Stock

Also insider at

DGX
QUEST DIAGNOSTICS INC Healthcare
Director
HT

Helen Torley

PRESIDENT AND CEO
Secaucus, NJ

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HALO